Skip to content
Riskpilot
← Back to search
Sign in
Get full access
REPONEX PHARMACEUTICALS A/S
A/S
Active
Advertising protection
CVR 30082346
Slotsmarken 12, 2970
Hørsholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2006 · 19 years old
1 employees
www.reponex.dk
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
REPONEX PHARMACEUTICALS A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-5M
-11M
-16M
-21M
-2M
2020
-9M
-350%
2021
-12M
-33%
2022
-17M
-42%
2023
-14M
+18%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
—
0
0
Staff expenses
-95
-0
-0
-0
-0
EBITDA
-2.145
-8.840
-12.043
-16.600
-13.507
Depreciation & amort.
-157
-3.763
-0
-0
-0
EBIT
-2.302
-12.604
-12.043
-16.600
-13.507
Net financials
-81
-251
-22
21
-251
Profit before tax
-2.383
-12.855
-12.065
-16.579
-13.759
Tax
-878
-2.971
-1.855
-2.233
-1.815
Net profit
-1.505
-9.883
-10.210
-14.346
-11.943
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
20.409
28.708
19.984
21.662
3.631
Equity
13.428
27.371
17.379
16.757
-8.785
Long-term debt
0
163
295
234
0
Short-term debt
5.492
1.174
2.311
4.671
12.416
Total debt
5.492
1.337
2.606
4.905
12.416
Financial ratios
5-year trend
EBITDA margin
-1350700000.0%
This company
15.8%
Market median
-8548734277% vs market
2020
2024
Equity ratio
-241.9%
This company
38.2%
Market median
-733% vs market
2020
2024
Return on equity
-1194300000.0%
This company
18.4%
Market median
-6490760970% vs market
2020
2024
Net profit margin
-1194300000.0%
This company
8.1%
Market median
-14744444544% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.41×
This company
0.62×
Market median
-127% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on REPONEX PHARMACEUTICALS A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
